­

Company News

med fusion and Theranostics Health Release Novel Cancer Theranostic Test

TheraLink™ HER Family Assay Provides Guidance for Directing Molecular Targeted Therapies Lewsiville, TX, May 29, 2013 med fusion and Theranostics Health will introduce the first of the TheraLink™ Assays for use in patients with malignant diseases at the American Society of Clinical Oncology (ASCO) Annual '13 Meeting, held in Chicago, [...]

May 29th, 2013|

med fusion, Pathologists Bio-Medical Laboratories (PBM) and Theranostics Health to Announce Availability of Novel Cancer Theranostic Test at ASCO

Lewsiville, TX, May 1, 2013 med fusion, Pathologists Bio-Medical Laboratories (PBM) and Theranostics Health will be introducing the first of Theranostics Health’s TheraLink™ Assays for use in patients with malignant diseases at the upcoming American Society of Clinical Oncology (ASCO) Annual ’13 Meeting, held in Chicago, IL from May 30, [...]

May 1st, 2013|

med fusion clin-labs supports “Choosing Wisely®”, an initiative recently announced by the American Society of Clinical Pathology

med fusion clin-labs supports “Choosing Wisely®”, an initiative recently announced by the American Society of Clinical Pathology (ASCP), urging physicians and patients to engage in important conversations about some medical tests and procedures that may provide little benefit and in some cases actually harm. “Choosing Wisely” means questioning is it [...]

April 11th, 2013|

med fusion becomes Carter BloodCare Bronze Partner

Based on med fusion's 2012 contribution to Carter BloodCare's community blood supply, we are now considered a Carter BloodCare Bronze Partner. As part of the Premier Partners program, our Bronze status means we have more opportunities for making a difference.

March 1st, 2013|

med fusion Partners with Theranostics Health to Advance Personalized Medicine for Patients with Cancer

Lewsiville, TX, August 15, 2012 med fusion and Theranostics Health have entered into a Market Development Agreement to validate the clinical utility of Theranostics’ TheraLink™ Assays for use in patients with malignant diseases. The goal of this relationship is to help accelerate advancement of new methods in molecular diagnostics testing [...]

August 15th, 2012|

Roche Diagnostics enters strategic alliance with med fusion that recognizes company as a Roche Molecular Center of Excellence

Indianapolis, June 5, 2012 Collaborative relationship designed to help accelerate advancement of new methods in molecular diagnostics testing and personalized predictive treatment Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the establishment of a strategic alliance with med fusion LLC in Lewisville, Texas, that designates the company as a Roche [...]

June 5th, 2012|

The cobas® HPV cervical screening test reports genotypes 16 and 18 concurrently with no additional cost or action needed by the patient or physician

The cobas® HPV test uncovers disease missed by cytology, providing more information about cancer risk in women with normal cytology (NILM) than pooled hrHPV testing alone. Approximately one in 10 women with normal cytology who were HPV 16+ and/or 18+ actually had high-grade cervical disease that was missed with cytology.1 [...]

May 13th, 2012|

med fusion lands large HCA contract

November 8, 2010 Dallas Business Journal med fusion has entered a contract with HCA North Texas to provide lab services for more than 30 HCA hospitals, outpatient surgery centers and other facilities in North Texas. "The agreement gives Dallas-based HCA hospitals immediate, local access to hundreds of complex tests performed [...]

November 8th, 2010|

med fusion achieves great success in recycling

Since med fusion began operation in May, the company has recycled approximately 42% of its waste stream. This includes standard items that are recycled including plastic, glass, paper, cardboard, toner cartridges and pallets. In addition to the standard items, med fusion has also been able to recycle other items such [...]

October 29th, 2010|

med fusion Enters Agreement with North Texas HCA to Provide Select Laboratory Testing Services

Lewisville, Texas – October 25, 2010 – med fusion, an integrated laboratory reference testing and trial services company, announced today it has entered into an agreement with HCA North Texas to provide local reference laboratory testing services, which are currently sent outside the North Texas community. Dallas-based HCA hospitals will [...]

October 25th, 2010|

med fusion CEO spoke at G-2 Annual Lab Institute 2010 Conference

Keith Laughman, President and CEO of med fusion, spoke at the Washington G-2 Reports 28th Annual Lab Institute 2010 Conference held October 13-15, 2010. To download a PDF of his PowerPoint presentation please click here.

October 13th, 2010|

med fusion to integrate clinical laboratory services and clinical trials services

Dallas, Texas – A new company integrating advanced laboratory services and clinical trials services announced it will operate under the name med fusion and will be headquartered in Dallas, Texas.   Baylor Health Care System, Texas Oncology PA, Pathologists Biomedical Laboratories LLP and US Oncology have joined to create a [...]

September 1st, 2010|